首页 | 本学科首页   官方微博 | 高级检索  
     


Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma
Authors:Taizo Uchimoto  Tatsuo Fukushima  Kazumasa Komura  Wataru Fukuokaya  Takahiro Adachi  Takeshi Hashimoto  Atsuhiko Yoshizawa  Ko Nakamura  Yusuke Yano  Kazuki Nishimura  Kyosuke Nishio  Keita Nakamori  Kosuke Iwatani  Shutaro Yamamoto  Fumihiko Urabe  Keiichiro Mori  Takafumi Yanagisawa  Shunsuke Tsuduki  Kiyoshi Takahara  Teruo Inamoto  Jun Miki  Takahiro Kimura  Yoshio Ohno  Ryoichi Shiroki  Shin Egawa  Haruhito Azuma
Affiliation:1. Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan;2. Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan;3. Department of Urology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan;4. Department of Urology, Fujita-Health University School of Medicine, Toyoake City, Aichi, Japan
Abstract:
Keywords:urothelial carcinoma  pembrolizumab  platinum-refractory  re-challenging chemotherapy  overall survival  objective response
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号